Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

NVAX | Novavax, Inc.

IndexRUT P/E- EPS (ttm)-7.27 Insider Own7.24% Shs Outstand94.40M Perf Week-1.35%
Market Cap690.06M Forward P/E- EPS next Y-0.95 Insider Trans0.00% Shs Float87.57M Perf Month-11.18%
Income-586.76M PEG- EPS next Q-1.33 Inst Own61.22% Short Float / Ratio45.78% / 4.40 Perf Quarter9.60%
Sales1.60B P/S0.43 EPS this Y80.34% Inst Trans5.07% Short Interest40.09M Perf Half Y21.03%
Book/sh-8.00 P/B- EPS next Y42.50% ROA-27.24% Target Price21.40 Perf Year-67.42%
Cash/sh5.47 P/C1.34 EPS next 5Y-1.25% ROE-898.20% 52W Range5.61 - 25.66 Perf YTD-28.89%
Dividend- P/FCF- EPS past 5Y7.76% ROI- 52W High-71.51% Beta1.71
Dividend %- Quick Ratio0.69 Sales past 5Y525.36% Gross Margin56.08% 52W Low30.42% ATR0.68
Employees1992 Current Ratio0.71 Sales Q/Q128.28% Oper. Margin-38.42% RSI (14)44.91 Volatility7.30% 8.72%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin-36.73% Rel Volume0.91 Prev Close7.13
ShortableYes LT Debt/Eq- EarningsAug 08 BMO Payout- Avg Volume9.12M Price7.31
Recom2.50 SMA20-9.22% SMA50-8.80% SMA200-16.71% Volume8,318,446 Change2.52%
Date Action Analyst Rating Change Price Target Change
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
May-20-22Initiated BofA Securities Underperform $35
Feb-23-22Reiterated B. Riley Securities Buy $315 → $265
Feb-22-22Resumed Jefferies Buy $198
Sep-25-23 01:34PM
Sep-21-23 11:24AM
09:39AM
07:30AM
Sep-19-23 01:13PM
09:35AM Loading…
Sep-15-23 09:35AM
Sep-14-23 09:37AM
05:00AM
Sep-13-23 10:07AM
08:12AM
04:51AM
Sep-12-23 05:22PM
02:03PM
10:26AM
09:33AM
06:00AM Loading…
06:00AM
Sep-11-23 04:03PM
02:12PM
02:07PM
Sep-08-23 04:31PM
12:24PM
12:00PM
Sep-07-23 11:55AM
11:31AM
11:20AM
Sep-06-23 01:16PM
01:06PM
05:30AM
Sep-05-23 08:59PM
12:10PM
06:15AM Loading…
Sep-01-23 06:15AM
Aug-31-23 10:33AM
10:07AM
09:27AM
Aug-30-23 07:29PM
Aug-29-23 07:30AM
Aug-28-23 06:16PM
Aug-27-23 06:10AM
Aug-25-23 09:16AM
06:08AM
Aug-24-23 10:15AM
Aug-23-23 10:32AM
08:27AM
05:00AM
Aug-22-23 04:46PM
01:17PM
12:30PM
10:29AM
10:25AM
07:29AM
07:12AM
07:00AM
Aug-21-23 04:50PM
04:27PM
04:18PM
Aug-18-23 04:05PM
01:30PM
Aug-17-23 10:14AM
09:45AM
Aug-14-23 12:44PM
Aug-11-23 08:50AM
Aug-10-23 06:48PM
09:15AM
Aug-09-23 06:35PM
10:37AM
Aug-08-23 04:56PM
02:55PM
10:32AM
10:30AM
10:15AM
09:11AM
08:18AM
08:00AM
06:55AM
06:37AM
04:44AM
Aug-07-23 11:32AM
Aug-04-23 09:21AM
Aug-03-23 12:25PM
Aug-01-23 09:25AM
05:30AM
Jul-31-23 06:24PM
Jul-20-23 10:07AM
08:15AM
Jul-13-23 02:39PM
09:22AM
08:50AM
07:00AM
Jul-11-23 02:30PM
10:24AM
06:34AM
Jul-10-23 04:38PM
04:25PM
04:09PM
12:27PM
12:12PM
12:07PM
Jul-07-23 06:17PM
12:02PM
Jul-06-23 03:25PM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dubovsky FilipPresident, R&DSep 16Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM
Dubovsky FilipPresident, R&DJun 16Option Exercise8.044,15533,40647,065Jun 21 04:40 PM
Glenn Gregory MPresident, R&DMar 10Option Exercise6.526,29841,06320,771Mar 14 05:16 PM
Trizzino JohnEVP, CCO and CBOMar 10Option Exercise6.524,60930,05111,531Mar 14 05:20 PM
Kelly James PatrickEVP, CFO and TreasurerMar 10Option Exercise6.524,60930,0515,832Mar 14 05:19 PM
Herrmann John A IIIEVP, Chief Legal OfficerMar 10Option Exercise6.524,60930,05113,058Mar 14 05:18 PM
Glenn Gregory MPresident, R&DMar 10Buy6.501,0006,50014,473Mar 14 05:16 PM
Glenn Gregory MPresident, R&DMar 07Buy7.042,00014,08813,473Mar 14 05:16 PM
Glenn Gregory MPresident, R&DMar 06Buy7.483,00022,45411,473Mar 14 05:16 PM